176 related articles for article (PubMed ID: 18683094)
21. ADL-2-1294 (Adolor).
Wheeler GD
IDrugs; 2000 Nov; 3(11):1373-8. PubMed ID: 16047259
[TBL] [Abstract][Full Text] [Related]
22. TRX-4 (TolerRx Inc).
Brown WM
IDrugs; 2006 Apr; 9(4):283-91. PubMed ID: 16596483
[TBL] [Abstract][Full Text] [Related]
23. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.
Flynn A; O'Brien T
IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964
[TBL] [Abstract][Full Text] [Related]
24. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
Steinberg M
Clin Ther; 2008 Sep; 30(9):1590-617. PubMed ID: 18840366
[TBL] [Abstract][Full Text] [Related]
25. Terameprocol, a novel site-specific transcription inhibitor with anticancer activity.
Smolewski P
IDrugs; 2008 Mar; 11(3):204-14. PubMed ID: 18311658
[TBL] [Abstract][Full Text] [Related]
26. Raltegravir: the first HIV integrase inhibitor.
Cocohoba J; Dong BJ
Clin Ther; 2008 Oct; 30(10):1747-65. PubMed ID: 19014832
[TBL] [Abstract][Full Text] [Related]
27. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
Fletcher PS; Shattock RJ
Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
[TBL] [Abstract][Full Text] [Related]
28. Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm.
Khan G; Merajver S
Expert Opin Investig Drugs; 2009 Apr; 18(4):541-8. PubMed ID: 19335282
[TBL] [Abstract][Full Text] [Related]
29. Drug evaluation: alfimeprase, a plasminogen-independent thrombolytic.
Shah AR; Scher L
IDrugs; 2007 May; 10(5):329-35. PubMed ID: 17487785
[TBL] [Abstract][Full Text] [Related]
30. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R
Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
[TBL] [Abstract][Full Text] [Related]
31. Technology evaluation: electroporation therapy, Genetronics Inc.
Orr RM
Curr Opin Mol Ther; 2000 Apr; 2(2):205-10. PubMed ID: 11249643
[TBL] [Abstract][Full Text] [Related]
32. Ammonium tetrathiomolybdate treatment of copper-associated hepatopathy in dogs.
Langlois DK; Querubin JR; Schall WD; Nelson NC; Smedley RC
J Vet Intern Med; 2019 May; 33(3):1336-1343. PubMed ID: 30883912
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
Hou G; Abrams GD; Dick R; Brewer GJ
Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
[TBL] [Abstract][Full Text] [Related]
34. GI-5005, a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection.
Habersetzer F; Baumert TF; Stoll-Keller F
Curr Opin Mol Ther; 2009 Aug; 11(4):456-62. PubMed ID: 19649991
[TBL] [Abstract][Full Text] [Related]
35. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Brewer GJ
Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
Tallaksen-Greene SJ; Janiszewska A; Benton K; Hou G; Dick R; Brewer GJ; Albin RL
Neurosci Lett; 2009 Mar; 452(1):60-2. PubMed ID: 19429000
[TBL] [Abstract][Full Text] [Related]
37. Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.
Shaw G; Oliver RT
Surg Oncol; 2009 Sep; 18(3):275-82. PubMed ID: 19269165
[TBL] [Abstract][Full Text] [Related]
38. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic drugs in ovarian cancer.
Markman M
Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
[TBL] [Abstract][Full Text] [Related]
40. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
van Eden W
Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
